Antipodes Partners’s Halliburton HAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,080,205
Closed -$35.6M 74
2023
Q2
$35.6M Sell
1,080,205
-2,254,375
-68% -$71.2M 1.23% 29
2023
Q1
$106M Buy
3,334,580
+817,692
+32% +$30.3M 3.66% 10
2022
Q4
$99M Buy
+2,516,888
New +$89.1M 3.55% 9
2022
Q2
Sell
-719,377
Closed -$27.2M 44
2022
Q1
$27.2M Buy
+719,377
New +$23.3M 0.97% 28

Other funds holding HAL

Antipodes Partners's HAL Position: Q3 2023 in Review

Antipodes Partners sold out of Halliburton (HAL) in Q3 2023, closing a stake of 1,080,205 shares — an estimated $35.6M sold.

Antipodes Partners first reported a position in HAL in Q1 2022 and held it in 4 quarters. The position peaked at $106M in Q1 2023. 957 funds tracked by Wall St. Rank hold HAL as of Q3 2023.

  • Antipodes Partners reported no remaining Halliburton position as of Q3 2023 after selling out during the quarter.
  • Antipodes Partners sold 1,080,205 Halliburton shares in Q3 2023, an estimated $35.6M.
  • Antipodes Partners first reported a position in Halliburton in Q1 2022 and held it in 4 quarters.
  • Antipodes Partners's Halliburton position peaked at $106M in Q1 2023.
  • 957 funds tracked by Wall St. Rank held Halliburton as of Q3 2023.

Based on Antipodes Partners's 13F filing for Q3 2023, filed 13 Nov 2023.